BioHeart (Weston, Florida) reported several staff additions. Brenda Jones was named director, clinical support and physician relations specialist. She previously was a physician relations specialist at Arterial Vascular Engineering, now Medtronic AVE. Richard Klein was named director of intellectual property and contracts. Klein had been vice president of intellectual property at AVE. Dan Fifer has been named senior research and development engineer. Previously, Fifer was a senior research and development engineer at AVE. Joe Tamayo was named director of regulatory affairs and quality assurance, Santa Rosa site. Fifer earlier was director of regulatory affairs and quality assurance at Cerus, Medtronic AVE and Surgidyne. Robert Michalik has been named director of regulatory affairs and quality assurance, Worcester site. He formerly was director of regulatory affairs and quality assurance at Boston Scientific. Bioheart is focused on regenerating damaged heart muscle with its Myocell cellular -based implant product.
CompuMed (Los Angeles, California) said it will not renew the employment agreement with Herbert Lightstone, president and CEO, that agreement expiring May 31. Lightstone will continue to serve as CEO until then, the company said. CompuMed is the producer of the OsteoGram diagnostic software product and telemedicine services for cardiology.
Ginger Graham has stepped down as group chairman at Guidant (Indianapolis, Indiana) to become an advisor to President and CEO Ronald Dollens. She will focus on business partnerships, recruitment and Guidant's women's health initiatives, the company said. Graham will be located in Boulder, Colorado. Additionally, Dana Mead Jr., currently president of the company's Japan, Asia/Pacific operations, was named vice president of corporate relations and policy, a new position. Mead joined Guidant in 1992 and was named to his most recent post in 2000. Rodney Nash has been promoted from vice president, corporate resources and policy, to vice president, Japan, Asia/Pacific and Latin America.
Richard diMonda has been promoted from vice president, clinical and strategic development, to vice president, scientific affairs and strategic development, at Novoste (Norcross, Georgia). Pia Mikkelsen Lynch, MD, has been named vice president, global clinical affairs, after serving as director of clinical research at Elan Pharmaceutical. Novoste develops brachytherapy systems for prevention of in-stent restenosis.
Richard Bader, CEO and a director of Raytel Medical (San Mateo, California), has resigned after his attempt to buy the company was rejected by the Raytel board in favor of a bid by Israeli firm SHL.